MEI-HWEI CHANG2021-01-042021-01-0420000277-2116https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033868615&doi=10.1097%2f00005176-200008000-00005&partnerID=40&md5=b7f6c10196b27dece3d0ff27cf47b64fhttps://scholars.lib.ntu.edu.tw/handle/123456789/537152[SDGs]SDG3hepatitis B vaccine; chronic hepatitis; disease association; disease control; disease course; epidemiological data; geographic distribution; hepatitis B; Hepatitis B virus; human; immunoprophylaxis; liver cell carcinoma; liver cirrhosis; priority journal; review; risk factor; vaccination; Carcinoma, Hepatocellular; Child; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Immunization; Liver Diseases; Liver Neoplasms; Hepatitis B virusreview10.1097/00005176-200008000-00005109419602-s2.0-0033868615